|
Volumn 6, Issue 2, 2007, Pages 121-138
|
Reliability of S100B in predicting severity of central nervous system injury
|
Author keywords
Assessment of CNS injury; Biomarker for brain injury; Clinical outcomes prediction; Glial fibrillary acidic protein (GFAP); Neuron specific enolase (NSE); S100B Protein; Secondary brain injury
|
Indexed keywords
BIOLOGICAL MARKER;
FIBRINOLYTIC AGENT;
GLIAL FIBRILLARY ACIDIC PROTEIN;
NEURON SPECIFIC ENOLASE;
PROTEIN S100B;
WARFARIN;
BIOCHEMISTRY;
BIOLOGICAL MONITORING;
BRAIN DEATH;
BRAIN HYPOXIA;
BRAIN INJURY;
CARDIOPULMONARY ARREST;
CENTRAL NERVOUS SYSTEM;
CEREBROSPINAL FLUID;
CEREBROVASCULAR DISEASE;
CHEMOLUMINESCENCE;
DIAGNOSTIC ACCURACY;
DISEASE SEVERITY;
HEAD INJURY;
HEART ARREST;
HUMAN;
IMMUNOASSAY;
IMMUNORADIOMETRIC ASSAY;
INTRACRANIAL PRESSURE;
MORTALITY;
MULTIPLE ORGAN FAILURE;
NERVOUS SYSTEM INJURY;
NEUROIMAGING;
NEUROLOGIC EXAMINATION;
OUTCOME ASSESSMENT;
PENETRATING TRAUMA;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
PROTEIN CEREBROSPINAL FLUID LEVEL;
PROTEIN DETERMINATION;
RELIABILITY;
RESUSCITATION;
REVIEW;
SAMPLING;
SENSITIVITY AND SPECIFICITY;
STROKE;
TREATMENT PLANNING;
TREATMENT RESPONSE;
UPREGULATION;
VALIDATION PROCESS;
BIOLOGICAL MARKERS;
BRAIN INJURIES;
CARDIOVASCULAR DISEASES;
HUMANS;
HYPOXIA, BRAIN;
NERVE GROWTH FACTORS;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
S100 PROTEINS;
|
EID: 34250628428
PISSN: 15416933
EISSN: None
Source Type: Journal
DOI: 10.1007/s12028-007-0008-x Document Type: Review |
Times cited : (163)
|
References (5)
|